Acta Scientific Clinical Case Reports

Editorial Volume 2 Issue 1

Unprecedented Challenges Need Unprecedented Solutions for Cancer Care

Md Abu Bashar1 and Nazia Begam2*

1Assistant Professor, Department of Community Medicine, Institute of Medical Sciences, BHU, Varanasi, Uttar Pradesh, India
2Specialist Medical Officer(ENT), ECHS Hospital, Ambala, Haryana, India

*Corresponding Author: Dr Md Abu Bashar, Assistant Professor, Department of Community Medicine, Institute of Medical Sciences, BHU, India..

Received: November 19, 2020; Published: November 28, 2020


  Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), resulting in COVID-19, is posing an insurmountable challenge to healthcare systems globally. Cancer therapy is complex, regimented, and outcomes are focused on timing. COVID-19 has thrown a gauntlet to an already strained system for cancer treatment. Given the extrinsic factors (e.g. resource constraints and high morbidity/mortality) of the COVID-19 pandemic and the intrinsic factors of patients with cancer (e.g. high-risk population, lower immune system, and many at advanced stage of disease), practitioners face great responsibilities in ensuring timely, appropriate, compassionate, and justified cancer care, while protecting themselves from becoming infected with COVID-19 [1]. The reported prevalence of cancer among patients with COVID-19 i.e. around 1% seems to be higher than its prevalence in the overall population [2]. Early data from two small, heterogeneous populations [3] showed that 39-54% of patients with cancer were reported to have a severe event (admission to intensive care unit, or death) when infected with COVID-19 [2,4]. Receiving antitumor chemo-or immuno-therapy or surgery within 2-4 weeks of developing symptoms of COVID-19 predicted worse outcomes [2,4]. The challenges imposed by COVID-19 impact every aspect of the existing paradigm of cancer care, starting with diagnosis all the way to end-of-life care for cancer patients, which raises concerns about patients receiving suboptimal care.



Citation: Md Abu Bashar and Nazia Begam. “Unprecedented Challenges Need Unprecedented Solutions for Cancer Care" Acta Scientific Clinical Case Reports 2.1 (2021): 01.


Acceptance rate35%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US